ACGL vs IX

ACGL presents a compelling value opportunity with a Piotroski F-Score of 4/9 (Stable) and a Graham Number of $130.62, indicating the current price of $97.06 is significantly undervalued. The company exhibits exceptional earnings performance, beating estimates in 4 of the last 4 quarters with a YoY earnings growth of 38.8%. While insider sentiment is bearish due to significant selling by the CEO and Chairman, the low P/E ratio of 8.37 and strong ROE of 19.54% provide a substantial margin of safety. The combination of explosive earnings growth and a defensive valuation makes the stock highly attractive despite the lack of dividends.

ORIX Corporation presents a stark contrast between strong valuation and weak fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the stock is significantly undervalued relative to its Graham Number ($39.02) and Intrinsic Value ($76.99), the low health score suggests deteriorating operational efficiency or financial stability. Strong earnings growth (36.6% YoY) and an exceptionally low forward P/E of 2.77 provide a bullish growth narrative, but these are offset by a bearish technical trend score and poor insider sentiment.